论文信息 - A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia - 字舞流文

A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia

S. Iida | K. Izutsu | Kenshi Suzuki | H. Handa | T. Ishikawa | H. Tatetsu | H. Shibayama | W. Munakata | N. Sekiguchi | N. Fukuhara | Y. Terui | Shinya Rai | N. Iwaki | T. Endo | Ryota Shiibashi | Hiro Tatetsu